Copertina

Sustained Remission in a Pediatric B‐Cell Acute Lymphoblastic Leukemia With Rare PAX5::KIAA1549L Fusion and Complex Karyotype Following Blinatumomab Consolidation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xiaoyong Chen, Junjie Hou, Hongjian Wang, Qiang Yao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
di: Qiang Yao, et al.
Pubblicazione: (2025)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
di: Angela Parra del Riego, et al.
Pubblicazione: (2026)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
di: Eesha A. Zaheer, et al.
Pubblicazione: (2026)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
di: Krunal Shah, et al.
Pubblicazione: (2025)

A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T‐Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications
di: Qiang Yao, et al.
Pubblicazione: (2025)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
di: Sue Zupanec, et al.
Pubblicazione: (2025)

A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
di: Dong Peng, et al.
Pubblicazione: (2026)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
di: Reena Pabari, et al.
Pubblicazione: (2025)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
di: Nicolò Peccatori, et al.
Pubblicazione: (2025)

Rare EWSR1::PBX1 Fusion‐Positive Infant B‐ALL With Coexisting KRAS Mutation: Sustained Molecular Remission Achieved With Standard Chemotherapy
di: Xiaoyong Chen, et al.
Pubblicazione: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
di: Mikhail Lemeshev, et al.
Pubblicazione: (2026)

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
di: Alda Daniela García‐Guzmán, et al.
Pubblicazione: (2025)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
di: Laura Almási, et al.
Pubblicazione: (2026)

Molecularly Informed Combination Therapy for BRAF‐KIAA1549 Fusion‐Positive Pilocytic Astrocytoma in a Resource‐Limited Setting
di: Yousef VatanParast
Pubblicazione: (2025)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
di: Ryo Hanaki, et al.
Pubblicazione: (2025)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
di: Ankita Chakraborty, et al.
Pubblicazione: (2026)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
di: Janna R. Shapiro, et al.
Pubblicazione: (2025)

Multiple Hematopoietic Stem Cell Transplantations in Pediatric Acute Myeloid Leukemia: Prognostic Significance of Remission and Severe Sinusoidal Obstruction Syndrome
di: Hideki Yoshida, et al.
Pubblicazione: (2025)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
di: Ashley C. Holland, et al.
Pubblicazione: (2025)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
di: Aida Zeckanovic, et al.
Pubblicazione: (2024)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
di: Andrew E. Place, et al.
Pubblicazione: (2025)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
di: Amrutha Narayana Murthy, et al.
Pubblicazione: (2025)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
di: Dany Assaf Curi, et al.
Pubblicazione: (2025)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
di: Ashley C. Holland, et al.
Pubblicazione: (2025)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
di: Fanqiao Meng, et al.
Pubblicazione: (2025)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
di: Marko Kavcic, et al.
Pubblicazione: (2025)

A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
di: Ajmeera A. Azeez, et al.
Pubblicazione: (2025)

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
di: Ava Momm, et al.
Pubblicazione: (2026)

A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
di: Qiang Yao, et al.
Pubblicazione: (2025)

Sedation with Oral Dexmedetomidine Premedication in Pediatric Patients With Acute Lymphoblastic Leukemia Undergoing Blood Sampling: A Randomized, Double‐Blind Clinical Trial
di: Farshad Khoddami, et al.
Pubblicazione: (2026)

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium
di: Emily J. Mason, et al.
Pubblicazione: (2026)

Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1‐Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure
di: Luca Lo Nigro, et al.
Pubblicazione: (2025)

Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
di: Donát Alpár, et al.
Pubblicazione: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
di: Kellee N. Parker, et al.
Pubblicazione: (2026)

Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
di: Yaoyao Rui, et al.
Pubblicazione: (2025)

Successful Medical Management of Gastrointestinal Invasive Mucormycosis with Associated Bowel Perforation in an Adolescent Patient with pre‐B Cell Acute Lymphoblastic Leukemia
di: Heather Valdin, et al.
Pubblicazione: (2025)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
di: Janna R. Shapiro, et al.
Pubblicazione: (2026)

CIC‐Rearrangements in Pediatric Acute Erythroid Leukemia/Erythroblastic Sarcoma
di: Alexandra L. Chang‐Graham, et al.
Pubblicazione: (2025)

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
di: Cassandra Grello, et al.
Pubblicazione: (2025)

Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments
di: Jammbe Musoro, et al.
Pubblicazione: (2024)